Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
Clinical trial NCT04776148 · COMPLETED
Trial details
- NCT number
- NCT04776148
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2024-09-27
- Enrollment
- 563
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.